DSG2 and squamous cell carcinoma: Moreover, overexpression of DSG2 in lung adenocarcinoma and squamous cell carcinoma cells activates EGFR and increases cancer cell proliferation and migration by c‐Src and EGFR‐dependent manner.58, 59